Ketone– tag –
-
FDA Approves World’s First Dual Glucose-Ketone Continuous Monitoring Wearable for Diabetes Patients: Early DKA Risk Detection Enabled
GIGAZINE Japan Overview GIGAZINE reports that the U.S. FDA has approved the world's first wearable device for continuous dual glucose and ketone monitoring in diabetes patients. This is Abbott's Libre Duo 10 Day, providing real-time data... -
FDA Clears First Continuous Glucose-Ketone Monitor: Abbott’s Libre Duo 10 Day Transforms Diabetes Care
Pharmacy Times USA Overview The FDA has authorized Abbott's Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for individuals aged 2 and older with diabetes. This marks the first continuous ketone monitoring wearable in t... -
HME News Reports: Abbott Gains FDA Clearance for Dual Sensing Technology, Marking New Step in DKA Prevention
HME News USA Overview HME News reports Abbott has received FDA authorization for its Libre Duo 10 Day system, which continuously monitors both glucose and ketones. This biowearable is designed to alert patients to rising ketone levels, c... -
Abbott’s Libre Duo 10 Day System Authorized by FDA: First US Continuous Dual Glucose-Ketone Wearable Provides Early DKA Warning for Diabetes Patients Ages 2+
Abbott & U.S. Food and Drug Administration (FDA) USA Overview Abbott's "Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System" has received FDA authorization, making it the first device in the US to continuously track ketone ... -
Wearable Biosensors Revolutionize Personal Health Monitoring in 2026: Real-time Tracking and Diverse Form Factors Enhance Chronic Disease Management
News-Medical.net UK Overview Wearable biosensors are fundamentally transforming personal health monitoring in 2026, shifting from intermittent clinical tests to continuous physiological recording. These devices enable real-time tracking ... -
Abbott Submits Dual Glucose-Ketone Sensor ‘Libre Duo’ to US FDA for DKA Prevention After European CE Mark
MedTech Dive USA Overview Abbott has filed an FDA application to launch its dual glucose-ketone sensor, Libre Duo, in the U.S. after receiving Europe's CE mark. Approval is expected by year-end, with the device aiming to prevent diabetic... -
UAE Breakthrough: Wearable Ketone Monitor Slashes DKA Emergencies by 60% for Type 1 Diabetics, Poised to Revolutionize Diabetes Management
Facebook UAE Overview Researchers in the UAE have engineered a pioneering wearable continuous ketone monitor (CKM) that tracks interstitial fluid ketone levels to avert diabetic ketoacidosis (DKA) in Type 1 diabetics. A clinical trial in... -
Wearable Multi-Analyte Biosensors Revolutionize Diabetes Monitoring and Personalized Medicine: A Comprehensive Review of Nanostructured Electrodes and Flexible Substrate Engineering
PMC (Review Article) International Overview This review article details the path to commercializing minimally and non-invasive glucose monitoring, alongside advances in non-invasive real-time analysis of sweat, saliva, tears, and interst... -
Abbott Secures CE Mark for Libre Duo Glucose-Ketone Sensor, Accelerates European Rollout of Consumer Lingo Biosensor
FreeStyle Libre Summer 2026 update Europe Overview Abbott obtained the European CE Mark in May 2026 for Libre Duo and Libre Duo 10 Day, capable of measuring both glucose and ketones for 15 days, with European market launch planned within... -
Smart Ring Continuously Tracks Glucose, Alcohol, and More via Sweat: UC San Diego Unveils Multi-Biomarker Sensing Technology
SciTechDaily USA Overview Engineers at the University of California San Diego have developed an experimental smart ring that continuously analyzes sweat from the finger to track multiple molecules, including glucose, ketones, vitamin C, ...
